Filing Details

Accession Number:
0000950170-24-026606
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 20:00:28
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 20:00:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
873303 Sarepta Therapeutics Inc. SRPT Pharmaceutical Preparations (2834) 930797222
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1959750 Bilal Arif 215 First Street
Cambridge MA 02129
Chief Tech Ops Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-01 251 $126.19 22,836 No 4 F Direct
Common Stock Acquisiton 2024-03-01 6,000 $0.00 28,836 No 4 A Direct
Common Stock Disposition 2024-03-01 1,543 $128.58 27,293 No 4 S Direct
Common Stock Disposition 2024-03-01 457 $129.71 26,836 No 4 S Direct
Common Stock Disposition 2024-03-01 114 $126.19 26,722 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-03-01 12,500 $0.00 12,500 $128.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2025-03-01 2034-03-01 No 4 A Direct
Footnotes
  1. Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.
  2. Amount of Securities Beneficially Owned includes 201 shares purchased under the Company's registered Employee Stock Purchase Plan on February 29, 2024.
  3. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
  4. Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.
  5. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.
  6. Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.